BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12768801)

  • 21. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Child and adolescent: a challenge for society, a priority for health system].
    Sommelet D
    Arch Pediatr; 2007 Aug; 14(8):1011-9. PubMed ID: 17572078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of statin therapy for the primary prevention of coronary heart disease.
    Walshe V; Nash A; Barry M
    Ir Med J; 2006 May; 99(5):144-5. PubMed ID: 16892920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic analysis of a school-based obesity prevention program.
    Wang LY; Yang Q; Lowry R; Wechsler H
    Obes Res; 2003 Nov; 11(11):1313-24. PubMed ID: 14627751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The medical care cost of childhood and adolescent cancer in Manitoba, 1990-1995.
    Luo W; Lane R; Stobart K; Morrison H; Schanzer D; Barr R; Greenberg M
    Chronic Dis Can; 2002; 23(3):83-90. PubMed ID: 12443564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
    Rahi JS; Manaras I; Tuomainen H; Hundt GL
    Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness in fall prevention for older women.
    Hektoen LF; Aas E; Lurås H
    Scand J Public Health; 2009 Aug; 37(6):584-9. PubMed ID: 19666674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Pediatric Alliance for Coordinated Care: evaluation of a medical home model.
    Palfrey JS; Sofis LA; Davidson EJ; Liu J; Freeman L; Ganz ML;
    Pediatrics; 2004 May; 113(5 Suppl):1507-16. PubMed ID: 15121919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of obesity on health service utilization and costs in childhood.
    Trasande L; Chatterjee S
    Obesity (Silver Spring); 2009 Sep; 17(9):1749-54. PubMed ID: 19300433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventable hospitalizations among children in California counties after child health insurance expansion initiatives.
    Cousineau MR; Stevens GD; Pickering TA
    Med Care; 2008 Feb; 46(2):142-7. PubMed ID: 18219242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
    Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network.
    Flabbee J; Petit N; Jay N; Guénard L; Codreanu F; Mazeyrat R; Kanny G; Moneret-Vautrin DA
    Allergy; 2008 Mar; 63(3):360-5. PubMed ID: 18269678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.